Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Overview on the Infections Related to Rare Candida Species Publisher



Kumar S1 ; Kumar A2 ; Roudbary M3 ; Mohammadi R4 ; Cernakova L5 ; Rodrigues CF6, 7, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Faculty of Biosciences, Institute of Biosciences and Technology, Shri Ramswaroop Memorial University, Uttar Pradesh, Barabanki, 225003, India
  2. 2. Department of Biotechnology, National Institute of Technology, Chhattisgarh, Raipur, 492010, India
  3. 3. Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, 1449614535, Iran
  4. 4. Department of Medical Parasitology and Mycology, Infectious Diseases and Tropical Medicine Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, 8174673461, Iran
  5. 5. Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovicova 6, Bratislava, 842 15, Slovakia
  6. 6. TOXRUN—Toxicology Research Unit, CESPU—Cooperativa de Ensino Superior Politecnico e Universitario, Gandra PRD, 4585-116, Portugal
  7. 7. LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, Porto, 4200-465, Portugal
  8. 8. ALiCE—Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, Porto, 4200-465, Portugal

Source: Pathogens Published:2022


Abstract

Atypical Candida spp. infections are rising, mostly due to the increasing numbers of immunocompromised patients. The most common Candida spp. is still Candida albicans; however, in the last decades, there has been an increase in non-Candida albicans Candida species infections (e.g., Candida glabrata, Candida parapsilosis, and Candida tropicalis). Furthermore, in the last 10 years, the reports on uncommon yeasts, such as Candida lusitaniae, Candida intermedia, or Candida norvegensis, have also worryingly increased. This review summarizes the information, mostly related to the last decade, regarding the infections, diagnosis, treatment, and resistance of these uncommon Candida species. In general, there has been an increase in the number of articles associated with the incidence of these species. Additionally, in several cases, there was a suggestive antifungal resistance, particularly with azoles, which is troublesome for therapeutic success. © 2022 by the authors.
Related Docs
View other Related Docs
1. Candida Africana Vulvovaginitis: Prevalence and Geographical Distribution, Journal de Mycologie Medicale (2020)
2. Molecular Identification and Antifungal Susceptibility Profiles of Candida Dubliniensis and Candida Africana Isolated From Vulvovaginal Candidiasis: A Single-Centre Experience in Iran, Mycoses (2021)
3. Differentiation of Candida Albicans Complex Species Isolated From Invasive and Non-Invasive Infections Using Hwp1 Gene Size Polymorphism, Current Medical Mycology (2021)
4. Candida Africana and Candida Dubliniensis As Causes of Pediatric Candiduria: A Study Using Hwp1 Gene Size Polymorphism, AIMS Microbiology (2020)
5. Catheter-Associated Blood Stream Infections Due to Candida Pararugosa in a Patient With Acute Myeloid Leukemia: A Case Report, Brazilian Journal of Microbiology (2023)
6. The First Case of Wickerhamomyces Anomalus Fungemia in Iran in an Immuneodeficient Child, a Review on the Literature, Journal of Medical Mycology (2023)
7. Candida Africana in Recurrent Vulvovaginal Candidiasis (Rvvc) Patients: Frequency and Phenotypic and Genotypic Characteristics, Journal of Medical Microbiology (2018)
8. Frequency of Uncommon Clinical Yeast Species Confirmed by Its-Sequencing, Archives of Clinical Infectious Diseases (2019)
Experts (# of related papers)
View all Related Experts
Rasoul Mohammadi (40)
Seyed Hossein Mirhendi Esfahani (36)
Other Related Docs
9. Candidemia in Children Caused by Uncommon Species of Candida, Archives of Pediatric Infectious Diseases (2018)
10. Molecular Characterization and Antifungal Susceptibilitytesting of Candida Nivariensis From Blood Samples – an Iranian Multicentre Study and a Review of the Literature, Journal of Medical Microbiology (2019)
11. An Alarming Rise of Non-Albicans Candida Species and Uncommon Yeasts in the Clinical Samples; a Combination of Various Molecular Techniques for Identification of Etiologic Agents, BMC Research Notes (2019)
12. Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces Glabrata Species Complex: A 5-Year Countrywide Study, Journal of Clinical Laboratory Analysis (2024)
13. Caspofungin-Non-Susceptible Candida Orthopsilosis Isolated From Onychomycosis in Iran, Iranian Journal of Public Health (2017)
14. Species Distribution and Susceptibility Profiles of Oral Candidiasis in Hematological Malignancy and Solid Tumor Patients, Brazilian Journal of Microbiology (2023)
15. Molecular Characterization of Candida Dubliniensis and Candida Albicans in the Oral Cavity of Drug Abusers Using Duplex Polymerase Chain Reaction, Current Medical Mycology (2018)
16. Antifungal Activity of Anethum Graveolens Extract and Atrovastatin Against Candida Species Compared to Fluconazole, Journal of Isfahan Medical School (2015)
17. Antifungal Susceptibility Analysis of Clinical Isolates of Candida Parapsilosis in Iran, Iranian Journal of Public Health (2016)
18. Candida Urinary Tract Infection Among Icu Patients in Isfahan, Iran, Archives of Clinical Infectious Diseases (2019)
19. Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia in Intensive Care Units in Isfahan, Iran, Current Medical Mycology (2022)
20. In Vitro Activity of Juglone (5-Hydroxy-1,4-Naphthoquinone) Against Both Fluconazole-Resistant and Susceptible Candida Isolates; [Actividad in Vitro De Juglona (5-Hidroxi-1,4-Naftoquinona) Contra Aislamientos De Candida Resistentes Y Sensibles a Fluconazol], Revista Iberoamericana de Micologia (2022)
21. Species Distribution and Antifungal Susceptibility Profile of Candida Isolates From Blood and Other Normally Sterile Foci From Pediatric Icu Patients in Tehran, Iran, Medical Mycology (2020)
22. Frequency of Candida Species Isolated From Patients in Children’S Medical Center, Tehran, Iran, Archives of Pediatric Infectious Diseases (2018)
23. Antifungal Susceptibility Testing of Candida Species Isolated From the Immunocompromised Patients Admitted to Ten University Hospitals in Iran: Comparison of Colonizing and Infecting Isolates, BMC Infectious Diseases (2017)
24. A 3-Year Study of Candida Infections Among Patients With Malignancy: Etiologic Agents and Antifungal Susceptibility Profile, Frontiers in Cellular and Infection Microbiology (2023)
25. Molecular Identification of Candida Species Isolated From Gastrooesophageal Candidiasis in Tehran, Iran, Gastroenterology and Hepatology from Bed to Bench (2015)
26. In Vitro Antifungal Susceptibility Pattern of Candida Species Isolated From Gastroesophageal Candidiasis, Gastroenterology and Hepatology from Bed to Bench (2021)
27. In-Vivo Efficiency of the Novel Azole Compounds (Attaf-1 and Attaf-2) Against Systemic Candidiasis in a Murine Model, Journal of Medical Mycology (2023)
28. Regulation of Erg3, Erg6, and Erg11 Genes in Antifungal-Resistant Isolates of Candida Parapsilosis, Iranian Biomedical Journal (2017)
29. Multicenter Identification and Antifungal Susceptibility Patterns of Candida Species Isolated From Clinical Samples, Jundishapur Journal of Microbiology (2017)
30. Candida Palmioleophila Candidemia and Bacterial Co-Infection in a 3-Month-Old Infant With Biliary Atresia, Frontiers in Cellular and Infection Microbiology (2023)
31. South Asian (Clade I) Candida Auris Meningitis in a Paediatric Patient in Iran With a Review of the Literature, Mycoses (2022)
32. Microbial Epidemiology of Candidaemia in Neonatal and Paediatric Intensive Care Units at the Children's Medical Center, Tehran, Mycoses (2018)
33. Epidemiology and Antifungal Susceptibility of Candida Species Isolated From 10 Tertiary Care Hospitals in Iran, Microbiology Spectrum (2022)
34. Low Level of Antifungal Resistance in Iranian Isolates of Candida Glabrata Recovered From Blood Samples in a Multicenter Study From 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of Pdr1, Antimicrobial Agents and Chemotherapy (2019)
35. The Evaluation of the Overexpression of the Erg-11, Mdr-1, Cdr-1, and Cdr-2 Genes in Fluconazole-Resistant Candida Albicans Isolated From Ahvazian Cancer Patients With Oral Candidiasis, Journal of Clinical Laboratory Analysis (2022)
36. In Vitro Activities of Six Antifungal Drugs Against Candida Glabrata Isolates: An Emerging Pathogen, Jundishapur Journal of Microbiology (2016)
37. Identification and Frequency of Candida Species in Patients With Different Forms of Candidiasis in Isfahan, Using Pcr-Rflp Method, Journal of Isfahan Medical School (2011)
38. Clinical and Mycological Study of Vulvovaginal Candidiasis (Vvc); Identification of Clinical Isolates by Polymerase Chain Reaction-Fragment Size Polymorphyim (Pcr-Fsp) Technique, Archives of Clinical Infectious Diseases (2017)
39. Multiplex Size Marker (Yeast Plex) for Rapid and Accurate Identification of Pathogenic Yeasts, Journal of Clinical Laboratory Analysis (2022)
40. Antifungal Effect of Atorvastatin in Comparison With Fluconazole on Candida Species Isolated From Patients Undergoing Head‑And‑Neck Radiotherapy, Dental Research Journal (2024)
41. Frequency of Candida Species in the Oral Cavity of Narcotics and Stimulants Smokers in Isfahan, Using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Method, Advanced Biomedical Research (2020)
42. Detection of Erg11 Point Mutations in Iranian Fluconazole-Resistant Candida Albicans Isolates, Current Medical Mycology (2019)
43. Antifungal Activity of Zingiber Officinale Rosc. Essential Oil Against Fluconazole Resistant Vaginal Isolates of Candida Albicans, Journal of Medicinal Plants (2007)
44. Identification of Candida Species Isolated From Renal Transplant Recipients With Candiduria, International Journal of Organ Transplantation Medicine (2016)
45. Candida Infections Among Neutropenic Patients, Caspian Journal of Internal Medicine (2016)
46. Identification of Candida Species and Antifungal Susceptibility in Cancer Patients With Oral Lesions in Ahvaz, Southern West of Iran, Advanced Biomedical Research (2020)
47. Functional Analysis of Two Stat1 Gain-Of-Function Mutations in Two Iranian Families With Autosomal Dominant Chronic Mucocutaneous Candidiasis, Medical Mycology (2021)
48. Epidemiologic and Antifungal Susceptibility Profile of Candiduria Among Patients Hospitalized in the Nephrology and Intensive Care Unit Wards, Tehran, Iran, Jundishapur Journal of Microbiology (2022)
49. Prevalence, Molecular Identification, and Genotyping of Candida Species Recovered From Oral Cavity Among Patients With Diabetes Mellitus From Tehran, Iran, Advanced Biomedical Research (2022)
50. Antifungal Effect of Atorvastatin Against Candida Species in Comparison to Fluconazole and Nystatin, Medicine and Pharmacy Reports (2019)